U.S. Launches Trade Probe into German Drug Price Plan

The U.S. has opened a trade investigation into Germany’s plans to cut spending on prescription drugs, a move that could lead to new tariffs on Europe’s largest economy.

U.S. Trade Representative Jamieson Greer announced the Section 301 probe Thursday, saying it would examine whether Germany’s “persistent underpayment for innovative pharmaceutical products” is unfair to American companies and burdens U.S. commerce.

“President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceutical research and development,” Greer said in a statement. He called Germany’s recent moves “a serious step…

Read the full article at BREITBART.COM